TY - JOUR A1 - Hammerschmidt, Thomas A1 - Bisanz, H. A1 - Wutzler, P. T1 - Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: An economic analysis JF - Vaccine N2 - Former economic analyses have shown that universal mass vaccination of infants against varicella using a one-dose schedule is cost-saving in Germany. In July 2006, an MMRV combination vaccine has been approved in Germany which shall be given in a two-dose schedule. We re-analysed our former analysis with the EVITA model in order to prove whether our former conclusion that universal mass vaccination against varicella is cost-saving is still valid when using a two-dose schedule vaccine. Indeed we found that universal mass vaccination of infants against varicella with a two-dose vaccine is cost-saving from societal as well as from health care perspective. KW - Varicella KW - Vaccination KW - Economics Y1 - 2018 PB - ELSEVIER ER - TY - JOUR A1 - Banz, K. A1 - Wagenpfeil, S. A1 - Neiss, A. A1 - Hammerschmidt, Thomas A1 - Wutzler, P. T1 - The burden of varicella in Germany JF - The European Journal of Health Economics KW - Varicella KW - Health Y1 - 2004 VL - 2004 IS - 5 / 1 SP - 46 EP - 53 ER -